4.3 Article

Interferon-Free Regimens: The Near Future, the Likely and the Not So Likely

期刊

CLINICS IN LIVER DISEASE
卷 15, 期 3, 页码 665-+

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.cld.2011.05.004

关键词

Chronic hepatitis C virus; Peginterferon; Sustained virologic response; Protease inhibitors; Polymerase inhibitors; IL28B genotype

资金

  1. Conatus
  2. Exalenz
  3. Human Genome Sciences
  4. Roche/Genentech
  5. Romark
  6. Abbott
  7. Anadys
  8. Bristol-Myers Squibb
  9. Gilead
  10. Globeimmune
  11. Zymogenetics

向作者/读者索取更多资源

Remarkable progress has been achieved in the treatment of chronic hepatitis C virus (HCV) since interferon was first used to treat this pathogen more than 20 years ago. This article reviews the mechanisms through which interferon is believed to suppress HCV and lead to SVR. These observations are used to speculate as to whether an all-oral antiviral cocktail could cure HCV in the near future.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据